
Applying to KAUST - Your Complete Guide for Masters & Ph.D. Programs (Upcoming Admissions)
Admissions Overview & Key Requirements

Opportunity type:
Fellowships
Funding Type:
Fully Funded
Regions:
Japan
Deadline:
2025-11-30
Opportunity type:
Fellowships
Funding Type:
Fully Funded
Regions:
Japan
Deadline:
2025-11-30
This fellowship, offered by the United Nations Office for Outer Space Affairs (UNOOSA) in collaboration with the Government of Japan and Kyushu Institute of Technology (Kyutech), invites applicants from developing or non–space-faring countries to pursue advanced degrees in nano-satellite technologies. The program begins on October 1, 2026, offering hands-on training, generous funding, and the experience of working in a leading space research environment in Japan.
Applicants must complete an online registration and submit documents, including:
For the PDF version of the required forms, please click here
For more detailed information, please visit the official website of the United Nations Office for Outer Space Affairs
Share

Applying to KAUST - Your Complete Guide for Masters & Ph.D. Programs (Upcoming Admissions)
Admissions Overview & Key Requirements

Erasmus Mundus Joint Master's 2026 (Upcoming Admissions)
Erasmus Mundus programs are scholarships available to students worldwide, offering fully-funded Master’s degrees to study in Europe!

Registration Opens for SAF 2025: International STEAM Azerbaijan Festival Welcomes Global Youth
The International STEAM Azerbaijan Festival (SAF) has officially opened registration for its 2025 edition!

KAIST International Graduate Admissions Spring 2026 in Korea (Fully Funded)
Applications are open for KAIST International Admissions for Master’s, Master’s-PhD Integrated, Ph.D., and Finance MBA

Young Leaders Union Conference 2025 in Paris (Fully Funded)
Join Global Changemakers in Paris! Fully Funded International Conference for Students, Professionals, and Social Leaders from All Nationalities and Fields

An mRNA cancer vaccine may offer long-term protection
A small clinical trial suggests the treatment could help keep pancreatic cancer from returning